Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from ZS

Zscaler: A Textbook Buy-the-Dip Opportunity

Zscaler had a solid quarter, outpacing the consensus estimates, but the whisper figures expected strength and weren't impressed, causing a buy-the-dip event.

MarketBeat

Zscaler Posts Q1 Beat: 8 Analysts Express Concern Around CFO Retirement, Guidance

Zscaler shares tanked despite upbeat Q1 results. The company raised its fiscal-year guidance and announced the departure of its CFO.

Benzinga

Zscaler's In-line Revenue Guidance Underwhelms Investors. CFO Retiring.

Zscaler stock fell after fiscal Q1 earnings and revenue beat estimates but in-line revenue guidance underwhelmed investors.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

A Preview Of Zscaler's Earnings

Zscaler (NASDAQ:ZS) is preparing to release its quarterly earnings on Monday, 2024-12-02. Here's a brief overview of what investors should keep in mind before the announcement.

Benzinga

3 Cloud Security Stocks Every Investor Should Watch

The cloud security sector is thriving, given the rising cyber threat concerns, demand for the latest technologies, and solid segment spending. Thus, quality cloud security stocks CrowdStrike Holdings (CRWD), Zscaler (ZS), and Check Point Software Technologies (CHKP) could be solid watchlist additions. Read more.

StockNews.com

Why Zscaler Stock Has Analysts So Excited

Having weathered a bumpy year so far, all signs point to Zscaler closing out 2024 on the front foot and starting 2025 with a pep in its step.

MarketBeat

1 Cybersecurity Stock to Grab This October

With cyberattacks on the rise, this cybersecurity stock presents a compelling buying opportunity this month.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Is Palo Alto Networks Stock Outperforming the Dow?

Palo Alto Networks has outperformed the Dow Jones Industrial Average over the past year, and Wall Street analysts remain bullish about the stock’s prospects.

Barchart

Zscaler Earnings Beat. Guidance Disappoints Amid Big Changes In Sales Organization.

Zscaler stock fell after the cybersecurity firm reported fiscal Q4 earnings that beat estimates while guidance underwhelmed investors.

Investors Business Daily

Option Volatility And Earnings Report For September 3 - 6

Earnings season is coming to an end, but we still have one or two important names to keep an eye on this week, lead by AI play Broadcom, discount retailer Dollar Tree plus Docusign, Dick’s Sporting Goods and Zscaler.

Barchart

Stocks Set to Open Lower as Investors Await U.S. Jobs Data

September S&P 500 E-Mini futures (ESU24) are down -0.46%, and September Nasdaq 100 E-Mini futures (NQU24) are down -0.69% this morning as trading resumed after the Labor Day holiday, with investors looking ahead to a new batch of U.S. labor market data, particularly Friday’s nonfarm payrolls report.

Barchart

3 'Strong Buy' Cybersecurity Stocks That Aren't CrowdStrike

With CrowdStrike's shares taking a massive hit following the recent global IT outage, here are three 'Strong Buy'-rated cybersecurity stocks to consider as compelling alternatives.

Barchart

2 'Strong Buy' Cybersecurity Growth Stocks to Grab Now

As the demand for cybersecurity solutions rises, here are two ‘Strong Buy’-rated cybersecurity growth stocks investors could grab now for potential gains.

Barchart

3 Growth Stocks to Grab for 29% Upside or More

These three promising growth stocks could deliver upside of 29% or more, according to analysts’ estimates.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Zscaler Touts Refocused Go-To-Market Strategy At Customer Conference

Analysts view Zscaler's customer conference as a positive for the cybersecurity firm's marketing strategy and for Zscaler stock.

The Street

Analysts revamp their Zscaler stock price targets after earnings

This is what could happen next to Zscaler shares.

Investors Business Daily

Zscaler Earnings, Revenue, Billings Top Estimates. Cybersecurity Stock Rises.

Zscaler stock shot up after it reported fiscal Q3 earnings that beat Wall Street targets. The cybersecurity firm's revenue guidance met expectations.

Investors Business Daily

Why Big Pharma Is Following Novartis' Lead In A $25 Billion Market

Novartis paved the way for radiopharmaceuticals. Now, Big Pharma thinks it can do better — and biotech stocks have soared on a spate of deals.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Zscaler Upgraded On View Competitive Position Stronger Than Wall Street Thinks

Cybersecurity firm Zscaler's competitive positioning in the SASE market looks better than Wall Street apparently thinks, says a KeyBanc Capital Markets analyst who upgraded the company.

Barchart

3 'Strong Buy' Cybersecurity Stocks to Scoop Up Now

These three cybersecurity stocks, all with ‘Strong Buy’ ratings from analysts, could be wise investments to benefit from the thriving cybersecurity industry amid growing digitization.

Barchart

3 'Strong Buy' Growth Stocks to Scoop Up Now

High-growth stocks, such as cybersecurity name Zscaler, could be part of your equity portfolio in 2024 - if you're the type of investor who can successfully stomach massive drawdowns in share prices and valuations.

The Street

Analysts race to reset CrowdStrike price targets after earnings surprise

Disappointing outlooks from Palo Alto Networks and Zscaler had put added pressure on CrowdStrike's fourth-quarter earnings.

Investors Business Daily

Zscaler Earnings Top Estimates, But Cybersecurity Stock Falls.

Zscaler reported fiscal Q2 earnings and revenue that topped Wall Street targets for ZS stock.

Investors Business Daily

Zscaler Falls As COO Resigns Amid Management Changes

The cybersecurity firm announced late Friday that Chief Operating Officer Dali Rajic had suddenly resigned.

Investors Business Daily

Why Big Pharma Led By Merck, Sanofi, Teva Are Pouring Billions Into A New Immunology Space

There's a revolution in immunology that could completely shift a paradigm biotech stocks. And Big Pharma is paying billions to get in.

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.